(Q28260403)

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

Working memory dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

The matter of mind: molecular control of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The relation between latent inhibition and symptom-types in young schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Animal behavior models of the mechanisms underlying antipsychotic atypicality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The gene encoding proline dehydrogenase modulates sensorimotor gating in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

G-protein-independent signaling mediated by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Evidence for silent synapses: implications for the expression of LTP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

NMDA receptor-dependent refinement of somatotopic maps.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Ionotropic and metabotropic glutamate receptor structure and pharmacology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Emotion circuits in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

AMPA receptor modulators as cognitive enhancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Postsynaptic factors in the expression of long-term potentiation (LTP): increased glutamate receptor binding following LTP induction in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Hippocampal synaptic plasticity and NMDA receptors: a role in information storage?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The pharmacology of latent inhibition as an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Mechanism and impact of allosteric AMPA receptor modulation by the ampakine CX546.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

NMDA receptor hypofunction model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Glutamate and depression: clinical and preclinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Src kinases: a hub for NMDA receptor regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Facilitation of glutamate receptors enhances memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Agonist- and subunit-dependent potentiation of glutamate receptors by a nootropic drug aniracetam

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Potentiation of NMDA and AMPA responses by the specific mGluR5 agonist CHPG in spinal cord motoneurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021

Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301191

7 January 2021